Summary We have analysed 174 gastric carcinomas from the United Kingdom and from Japan for the presence of Epstein-Barr virus (EBV) using in situ hybridisation for the small EBV-encoded nuclear RNAs (EBERs). EBV was detected in the tumour cells in all of six undifferentiated gastric carcinomas with prominent lymphoid stroma (undifferentiated carcinomas of nasopharyngeal type, UCNT) but only in three of the remaining 168 typical gastric adenocarcinomas (1.8%). No differences were observed between the British and the Japanese cases. One case with an EBV-positive UCNT showed adjacent areas of EBV-negative typical adenocarcinoma. It is uncertain whether these patterns represent two independent carcinomas or whether they are the result of heterogenous EBV infection in a single tumour. In the remaining EBV-positive carcinomas, viral transcripts were detected in virtually all tumour cells, indicating that EBV infection must have taken place early in the neoplastic process and suggesting that the virus is likely to be of pathogenetic significance for the virus-associated tumours. Immunohistology demonstrated absence of detectable levels of the EBV-encoded latent membrane protein, LMPI, and nuclear antigen, EBNA2. The BZLFI protein which induces the switch from latent to lytic infection was demonstrated in a small proportion of the tumour cells in three cases. The close association of EBV with undifferentiated gastric carcinomas compared to the variable association with gastric adenocarcinomas suggests fundamentally different roles for the virus in the aetiology of these two malignancies.
The Epstein-Barr virus (EBV) is well known for its association with several human malignancies such as Burkitt's lymphoma (BL) and Hodgkin's disease (HD) (Herbst et al., 1991; Herbst et al., 1993; Miller, 1990a; Zur Hausen et al., 1970) . However, the tumour showing world wide the strongest association with the virus is an epithelial neoplasm, undifferentiated nasopharyngeal carcinoma (NPC) (Klein, 1979) . Undifferentiated NPC is endemic in certain geographic areas, e.g. Southern China and North Africa, while it occurs only sporadically in Western Europe and North America (Klein, 1979) . However, EBV DNA is detected in virtually all cases regardless of geographic origin (Klein, 1979) . The small EBV-encoded nuclear RNAs (EBERs) are expressed in all EBV-positive cases (Niedobitek et al., 1992b; Wu et al., 1991) , and the transformation-associated protein of EBV, latent membrane protein 1 (LMP1), is detectable in a proportion of cases (Fahraeus et al., 1988; Niedobitek et al., 1992b; Young et al., 1988) .
In the nasopharynx, EBV appears to be associated exclusively with undifferentiated carcinomas but not with squamous cell carcinomas (Klein et al., 1974; Klein, 1979; Niedobitek et al., 1991a; 1993a) . Undifferentiated NPC display a number of characteristic morphological features, including a prominent lymphoid stroma which is seen in most cases. In recent years, carcinomas with similar morphological features (undifferentiated carcinomas of nasopharyngeal type, UCNT) from other anatomical sites have been analysed for the presence of EBV. These studies have led to the identification of a new EBV-associated tumour entity, gastric UCNT (Burke et al., 1990; Min et al., 1991; Niedobitek et al., 1992a; Shibata et al., 1991; Watanabe et al., 1976) . Although the total number of cases studied is low, the available evidence suggests a similarly strong association of gastric UCNT with EBV as seen with undifferentiated NPC. Also, cases from different geographic areas appear to be invariably EBV positive (Burke et al., 1990; Min et al., 1991; Niedobitek et al., 1992a; Shibata et al., 1991) . More recently, a study from the USA has also reported expression of the EBER transcripts in the tumour cells of 16% of classical gastric adenocarcinomas (Shibata & Weiss, 1992) .
We have analysed a large series of gastric carcinomas comprising cases from the United Kingdom and from Japan for the presence of EBV using in situ hybridisation for the detection of the EBER transcripts. EBV positive cases were further studied by immunohistology with monoclonal antibodies for the detection of latent and replicative viral antigens.
Materials and methods

Tissues
Formalin-fixed and paraffin-embedded tissue samples from 174 gastric carcinomas obtained from resection specimens were studied. 120 cases were from Birmingham, UK, and 54 specimens were from Nagoya, Japan. The Japanese cases included three cases specifically selected for their NPC-like morphological features. The age range of the UK cases was from 35 years to 87 years with a mean age of 66 years. The male-to-female ratio of the British cases was 2.03. The age range of the Japanese cases was from 33 years to 84 years with a mean age of 63 years. The male-to-female ratio of the Japanese cases was 1.17. The pathological characteristics of the cases are summarised in Table I . Paraffin blocks of an EBV-induced lymphoma arising in a cottontop tamarin were kindly provided by Dr A. Morgan and S. Finerty, University of Bristol, Bristol, UK.
In situ hybridisation
Digoxigenin-or 35S-labelled RNA probes were generated by in vitro transcription from the plasmids pBSJJJI and pBSJJJ2 harbouring EBER1-and EBER2-specific inserts, respectively (Niedobitek et al., 1991b) . To increase sensitivity, antisense probes derived from the two plasmids were mixed. Likewise, the two sense control probes were mixed. Prehybridisation treatment of tissue sections, hybridisation conditions and posthybridisation washes were as described previously (Niedobitek et al., 1991b; Niedobitek et al., 1993a , 1980) . Immobilised digoxigenin-labelled probe was detected using a digoxigeninspecific mouse monoclonal antibody and conventional immunohistology using the alkaline phosphatase-anti-alkaline phosphatase (APAAP) method (Niedobitek et al., 1993a) .
35S-labelled probe was detected by autoradiographic techniques using Ilford G5 emulsion as described previously (Niedobitek et al., 1991b) .
Immunohistology
The monoclonal antibodies, CS1-4, specific for LMPI (Rowe et al., 1987) , PE-2, directed against the EBV-encoded nuclear antigen, EBNA2 (Young et al., 1989a) , and BZ-1, specific for the BZLF1 protein (Young et al., 1991) were obtained from Dakopatts, Glostrup, Denmark. Before application of the primary antibodies and APAAP immunohistochemistry, paraffin sections were exposed to microwave irradiation in 0.01 M citrate buffer, pH 6, for 40 min. This pre-treatment was shown to improve staining with the CSl-4 reagent, and to render the EBNA2 and BZLF1 proteins detectable in paraffin sections (unpublished observation). In situ hybridisation revealed expression of the EBER transcripts in the tumour cell nuclei of all of six UCNT and in three of 168 (1.8%) typical gastric adenocarcinomas (Table  II) . Five of the patients with EBV-positive carcinomas were male and two were female. (Klein, 1979) . EBV DNA and viral gene products are detectable in virtually all cases of undifferentiated NPC, but not in squamous cell carcinomas of the same site (Klein et al., 1974; Klein, 1979; Niedobitek et al., 1991a; Niedobitek et al., 1993a; Zur Hausen et al., 1970) . Studies addressing the possible association of EBV with carcinomas arising outside the nasopharynx have demonstrated the presence of EBV DNA in salivary gland UCNT in Greenland Eskimos but not in Danish Caucasians (Hamilton-Dutoit et al., 1991) . Furthermore, several reports have suggested the possibility of an association of gastric UCNT with EBV (Burke et al., 1990; Min et al., 1991; Niedobitek et al., 1992a; Shibata et al., 1991) . In this study, expression of the EBER transcripts was observed in all of six gastric UCNT. Three of these cases were from Japan and three were from the United Kingdom. Thus, our results further support the observation that gastric UCNT are closely associated with EBV and, in conjunction with other studies, suggest that, like undifferentiated NPC, these tumours are EBV-positive in all geographic regions. More recently, Shibata and Weiss (1992) have reported the presence of EBV also in 16% of typical gastric adenocar- cinomas from the USA. This observation was surprising because previous evidence had suggested an association of EBV exclusively with undifferentiated carcinomas (Niedobitek et al., 1993b ). Here we demonstrate expression of the EBER transcripts in three of 168 gastric adenocarcinomas (1.8%), indicating latent EBV infection in the tumour cells. The difference between our results and the 16% incidence of EBV-positive gastric adenocarcinomas reported by Shibata and Weiss (1992) (Miller, 1990a) . Therefore, the possibility of geographic variation in the EBVassociation of gastric adenocarcinomas was examined in this study by comparing cases from the United Kingdom and from Japan. In both series, not more than 2% of the tumours were EBV-positive, thus excluding major differences between these two regions. It appears therefore, that EBV is not a major aetiological agent in the development of gastric adenocarcinomas in Western Europe and Japan. However, in view of the report by Shibata and Weiss (1992) , the possibility of epidemiological differences between these two regions and the USA remains and requires further investigation. Shibata and Weiss (1992) also reported an almost exclusive association of EBV with adenocarcinomas in male patients. Whilst a predominance of male patients amongst the EBV-positive cases was also found in our study, the numbers appear too small to draw any firm conclusions.
Immunohistological analysis of the EBV-positive cases revealed the absence of detectable levels of the EBNA2 and LMP1 proteins of EBV. These data are in line with previous reports demonstrating the consistent lack of EBNA2 expression in EBV-associated carcinomas (Fahraeus et al., 1988; Niedobitek et al., 1992b; Young et al., 1988) . By contrast, we and others have demonstrated that between 20 and 60% of undifferentiated NPC show detectable levels of LMP1 expression (Fahraeus et al., 1988; Niedobitek et al., 1992a; Young et al., 1988) . Thus, the absence of this viral protein from all 9 EBV-positive gastric carcinomas is unexpected. However, more cases and preferably snap frozen material will have to be analysed to clarify this point. Expression of the BZLF1 transactivator protein of EBV in a small proportion of tumour cells was demonstrated in three of nine EBV-positive carcinomas. Two of these were UCNT, one was an adenocarcinoma of mixed type. The BZLF1 protein is an early viral protein disrupting EBV latency in B lymphocytes, and its expression in B lymphocytes and in epithelial cells precedes the expression of the lytic cycle antigens associated with virus replication (Miller, 1990b; Young et al., 1991) . However, BZLF1 expression is not necessarily followed by realisation of the full lytic cycle. Our results are in agreement with a report demonstrating BZLF1 expression in an isolated case of gastric UCNT (Niedobitek et al., 1992a) . By contrast, we have previously demonstrated the absence of the BZLF 1 protein from undifferentiated NPC (Niedobitek et al., 1992b (Fingeroth et al., 1984) . The possible expression of this molecule in epithelial cells is still a matter of controversy (Birkenbach et al., 1992; Niedobitek et al., 1989; Sixbey et al., 1989; Thomas & Crawford, 1989; Young et al., 1989b (Sixbey & Yao, 1992) , and this mechanism may account for the infection of gastric mucosa.
However, both hypotheses would not easily explain the apparent restriction of EBV infection to undifferentiated carcinomas of nasopharynx, salivary glands and stomach.
The fact that EBV is detectable in all undifferentiated NPC and also in all gastric UCNT suggests that EBV infection may be a rate limiting step for the development of these tumours. Furthermore, it raises the possibility that EBV infection somehow prevents differentiation in infected epithelial cells (Dawson et al., 1990; Fahraeus et al., 1990) . The close association of EBV with gastric UCNT compared to the variable association with gastric adenocarcinomas suggests fundamentally different roles for the virus in the aetiology of these two malignancies.
